跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KERN PHARMA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KERN PHARMA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KERN PHARMA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 8, 2020
Approval ID
b6a522f5242ea334
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
b6a522f5242ea334
Drug Cima Aemps Name
OLMESARTAN/AMLODIPINO/HIDROCLOROTIAZIDA KERN PHARMA 40 MG/10 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85129
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2020-06-08
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
40mg /10 mg/ 25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
OLMESARTAN MEDOXOMILO
40 mg
AMLODIPINO BESILATO
13,868 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 8, 2020
Approval ID
b6a522f5242ea334
Type
Standard
Back to CIMA-AEMPS Approvals